AR099165A2 - A DIAMINIC COMPOUND, INTERMEDIARIES FOR THEIR PREPARATION, ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT, MEDICINAL PRODUCT, INHIBITOR OF THE ACTIVATED BLOOD FACTOR X, ANTICOAGULANT, MEDICATION TO PREVENT AND / OR TREAT THROMBOSIS OR EMBOLITION COMBINATION, PROCEDURE THE PREPARATION OF SUCH COMPOSITION - Google Patents
A DIAMINIC COMPOUND, INTERMEDIARIES FOR THEIR PREPARATION, ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT, MEDICINAL PRODUCT, INHIBITOR OF THE ACTIVATED BLOOD FACTOR X, ANTICOAGULANT, MEDICATION TO PREVENT AND / OR TREAT THROMBOSIS OR EMBOLITION COMBINATION, PROCEDURE THE PREPARATION OF SUCH COMPOSITIONInfo
- Publication number
- AR099165A2 AR099165A2 ARP150100181A ARP150100181A AR099165A2 AR 099165 A2 AR099165 A2 AR 099165A2 AR P150100181 A ARP150100181 A AR P150100181A AR P150100181 A ARP150100181 A AR P150100181A AR 099165 A2 AR099165 A2 AR 099165A2
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- medicinal product
- composition
- anticoagulant
- inhibitor
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 208000007536 Thrombosis Diseases 0.000 title abstract 2
- 239000003146 anticoagulant agent Substances 0.000 title abstract 2
- 229940127219 anticoagulant drug Drugs 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 2
- 229960000182 blood factors Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- -1 5-chloropyridin-2-yl Chemical group 0.000 abstract 1
- 208000005189 Embolism Diseases 0.000 abstract 1
- 108010074860 Factor Xa Proteins 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
N¹-(5-cloropiridin-2-il)-N²-(4-[(dimetilamino)carbonil]-2-{[(5-metil-4,5,6,7-tetrahidrotiazolo[5,4-c]piridin-2-iI)-carbonil]amino}ciclohexil)-etanodiamida de fórmula (1) o una sal de la misma, intermediarios para su preparación, su uso para la preparación de un medicamento, medicamento, inhibidor del factor x de coagulación sanguínea activado, anticoagulante, medicamento para prevenir y/o tratar trombosis o embolia y composición medicinal que lo comprenden, procedimiento para la preparación de dicha composición.N¹- (5-chloropyridin-2-yl) -N²- (4 - [(dimethylamino) carbonyl] -2 - {[(5-methyl-4,5,6,7-tetrahydrotiazolo [5,4-c] pyridin) -2-iI) -carbonyl] amino} cyclohexyl) -ethanediamide of formula (1) or a salt thereof, intermediates for its preparation, its use for the preparation of a medicament, medicament, activated blood coagulation factor x inhibitor , anticoagulant, medicine to prevent and / or treat thrombosis or embolism and medicinal composition comprising it, a procedure for the preparation of said composition.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001187105 | 2001-06-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR099165A2 true AR099165A2 (en) | 2016-07-06 |
Family
ID=58698431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150100181A AR099165A2 (en) | 2001-06-20 | 2015-01-22 | A DIAMINIC COMPOUND, INTERMEDIARIES FOR THEIR PREPARATION, ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT, MEDICINAL PRODUCT, INHIBITOR OF THE ACTIVATED BLOOD FACTOR X, ANTICOAGULANT, MEDICATION TO PREVENT AND / OR TREAT THROMBOSIS OR EMBOLITION COMBINATION, PROCEDURE THE PREPARATION OF SUCH COMPOSITION |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR099165A2 (en) |
-
2015
- 2015-01-22 AR ARP150100181A patent/AR099165A2/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0207760A (en) | Pharmaceutical composition, use thereof, methods for treating pain and inflammation, and process for preparing a composition | |
| BR0116370A (en) | Compound, pharmaceutical composition, use of a compound, and method of treating an hppar-mediated disease or condition in a patient. | |
| ECSP034883A (en) | AMIDAS OF ANTRANILIC ACIDS WITH SIDE CHAIN OF HETEROARILSULFONILO, PROCEDURE FOR THEIR PREPARATION, ITS EMPLOYMENT AS A MEDICINAL OR DIAGNOSTIC AGENT, AS WELL AS PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
| AR019853A1 (en) | DERIVED FROM THE 3-ARIL-2-HYDROXIPROPIONIC ACID, PROCESS AND INTERMEDIARY FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATIONS, USE OF SUCH COMPOUND IN THE PREPARATION OF A MEDICINAL PRODUCT, METHOD FOR THE PROPHYLAXIS AND / OR TREATMENT OF CLINIC ASSOCIATED RESISTANCES AND FORMULATION | |
| BRPI0308663B8 (en) | use of IL-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases | |
| BR0314797A (en) | Pyrimidineamide derivatives and their use | |
| BRPI0114344B8 (en) | retinoid compound, its use, its pharmaceutical composition and its preparation process | |
| BR0316458A (en) | Compound, pharmaceutical composition, method of treating or preventing disease, method for enhancing cognition in a healthy patient, and use of a compound | |
| WO2004100893A3 (en) | Methods for treatment of inflammatory diseases using ct-3 or analogs thereof | |
| NO20043792L (en) | New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine | |
| ES2124983T3 (en) | USE OF A SUBSTANCE P ANTAGONIST FOR THE TREATMENT OF RED SKIN STAINS OF NEUROGENOUS ORIGIN. | |
| DK1343472T3 (en) | Thixotropic nasal spray | |
| NO912414L (en) | RELATIONSHIP WITH MAGIC ACID INHIBITING EFFECT AND PROCEDURE FOR ITS MANUFACTURING. | |
| WO2003018535A3 (en) | Novel aminobenzoephenones | |
| ATE400563T1 (en) | NEW NEUROKININ ANTAGONISTS FOR USE AS MEDICINAL PRODUCTS | |
| DE60043886D1 (en) | FORMULATIONS WITH POVIDONE IOD FOR THE TREATMENT OF WOUNDS | |
| BR9913982A (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases | |
| AR099165A2 (en) | A DIAMINIC COMPOUND, INTERMEDIARIES FOR THEIR PREPARATION, ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT, MEDICINAL PRODUCT, INHIBITOR OF THE ACTIVATED BLOOD FACTOR X, ANTICOAGULANT, MEDICATION TO PREVENT AND / OR TREAT THROMBOSIS OR EMBOLITION COMBINATION, PROCEDURE THE PREPARATION OF SUCH COMPOSITION | |
| DE60045638D1 (en) | AVOIDANCE AND TREATMENT OF DISEASES RELATED TO THE BLOODS | |
| SE0004827D0 (en) | Therapeutic compounds | |
| ES2105643T3 (en) | USE OF 2- (4- (4-CHLOROFENIL) CICLOHEXIL) -3-HIDROXI-1,4-NAFTOQUINONE FOR THE TREATMENT OF CANCER. | |
| WO2003043632A3 (en) | Use of bisindolmaleimide and gemcitabine for the treatment of cancer | |
| MC2142A1 (en) | TOXOPLASMOSIS MEDICINE | |
| BRPI0415546A (en) | compound, pharmaceutical composition, use of a compound, and methods of treatment or prophylaxis of human diseases or conditions, and disorders | |
| ATE107504T1 (en) | MEDICATIONS FOR THE TREATMENT OF CRYPTOSPORIDIOSIS. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |